Report Thumbnail
Product Code LP0912910475V8N
Published Date 2023/2/4
English132 PagesGlobal

Global Pet DR Market Growth 2023-2029Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code LP0912910475V8N◆The Feb 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2023/2/4
English 132 PagesGlobal

Global Pet DR Market Growth 2023-2029Pharmaceutical_LifeSciense Market



Abstract


Summary

According to our LPI (LP Information) latest study, the global Pet DR market size was valued at US$ million in 2022. With growing demand in downstream market, the Pet DR is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Pet DR market. Pet DR are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pet DR. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pet DR market.
Pet DR (Digital Radiography) refers to the use of digital technology for capturing and processing X-ray images of pets, rather than traditional film-based systems. Pet DR systems utilize electronic sensors to capture the X-ray image and convert it into a digital format, allowing for faster processing, immediate image review, and greater efficiency in the diagnostic process. These systems also offer advantages such as lower radiation exposure for pets and the ability to share images with veterinarians and specialists remotely, improving the overall quality of care for pets.
The industry trend of Pet DR is experiencing growth and increasing adoption in the veterinary field. As technology advances and becomes more affordable, veterinarians are increasingly turning to digital radiography systems to improve the quality and efficiency of their diagnostic services. The trend is driven by the need for faster and more accurate diagnoses, as well as the desire to reduce the stress and discomfort experienced by pets undergoing imaging procedures. Additionally, the ability to share images with specialists and other veterinarians in real-time is becoming increasingly important in providing the best possible care for pets.
Key Features:
The report on Pet DR market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pet DR market. It may include historical data, market segmentation by Type (e.g., Fixed, Mobile), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pet DR market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pet DR market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pet DR industry. This include advancements in Pet DR technology, Pet DR new entrants, Pet DR new investment, and other innovations that are shaping the future of Pet DR.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pet DR market. It includes factors influencing customer ' purchasing decisions, preferences for Pet DR product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pet DR market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pet DR market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pet DR market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pet DR industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pet DR market.
Market Segmentation:
Pet DR market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Fixed
Mobile
Segmentation by application
Pet Hospital
Pet Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Visaris
Carestream
Americomp
Mednva
Basda
BMI Biomedical International
Agfa-Gevaert Group
Onex Corporation
CONTROL-X Medical
Examion
IBIS X Ray Systems
Heska
Air Techniques
Dawei Medical
Shenzhen Mindray Animal Medical Technology
Suzhou Genray Technology
Shenzhen RWD
Perlove
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pet DR market?
What factors are driving Pet DR market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet DR market opportunities vary by end market size?
How does Pet DR break out type, application?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Pet DR Annual Sales 2018-2029
      • 2.1.2 World Current & Future Analysis for Pet DR by Geographic Region, 2018, 2022 & 2029
      • 2.1.3 World Current & Future Analysis for Pet DR by Country/Region, 2018, 2022 & 2029
    • 2.2 Pet DR Segment by Type
      • 2.2.1 Fixed
      • 2.2.2 Mobile
    • 2.3 Pet DR Sales by Type
      • 2.3.1 Global Pet DR Sales Market Share by Type (2018-2023)
      • 2.3.2 Global Pet DR Revenue and Market Share by Type (2018-2023)
      • 2.3.3 Global Pet DR Sale Price by Type (2018-2023)
    • 2.4 Pet DR Segment by Application
      • 2.4.1 Pet Hospital
      • 2.4.2 Pet Clinic
      • 2.4.3 Other
    • 2.5 Pet DR Sales by Application
      • 2.5.1 Global Pet DR Sale Market Share by Application (2018-2023)
      • 2.5.2 Global Pet DR Revenue and Market Share by Application (2018-2023)
      • 2.5.3 Global Pet DR Sale Price by Application (2018-2023)
  • 3 Global Pet DR by Company

    • 3.1 Global Pet DR Breakdown Data by Company
      • 3.1.1 Global Pet DR Annual Sales by Company (2018-2023)
      • 3.1.2 Global Pet DR Sales Market Share by Company (2018-2023)
    • 3.2 Global Pet DR Annual Revenue by Company (2018-2023)
      • 3.2.1 Global Pet DR Revenue by Company (2018-2023)
      • 3.2.2 Global Pet DR Revenue Market Share by Company (2018-2023)
    • 3.3 Global Pet DR Sale Price by Company
    • 3.4 Key Manufacturers Pet DR Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Pet DR Product Location Distribution
      • 3.4.2 Players Pet DR Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    • 3.6 New Products and Potential Entrants
    • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Pet DR by Geographic Region

    • 4.1 World Historic Pet DR Market Size by Geographic Region (2018-2023)
      • 4.1.1 Global Pet DR Annual Sales by Geographic Region (2018-2023)
      • 4.1.2 Global Pet DR Annual Revenue by Geographic Region (2018-2023)
    • 4.2 World Historic Pet DR Market Size by Country/Region (2018-2023)
      • 4.2.1 Global Pet DR Annual Sales by Country/Region (2018-2023)
      • 4.2.2 Global Pet DR Annual Revenue by Country/Region (2018-2023)
    • 4.3 Americas Pet DR Sales Growth
    • 4.4 APAC Pet DR Sales Growth
    • 4.5 Europe Pet DR Sales Growth
    • 4.6 Middle East & Africa Pet DR Sales Growth
  • 5 Americas

    • 5.1 Americas Pet DR Sales by Country
      • 5.1.1 Americas Pet DR Sales by Country (2018-2023)
      • 5.1.2 Americas Pet DR Revenue by Country (2018-2023)
    • 5.2 Americas Pet DR Sales by Type
    • 5.3 Americas Pet DR Sales by Application
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Pet DR Sales by Region
      • 6.1.1 APAC Pet DR Sales by Region (2018-2023)
      • 6.1.2 APAC Pet DR Revenue by Region (2018-2023)
    • 6.2 APAC Pet DR Sales by Type
    • 6.3 APAC Pet DR Sales by Application
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Pet DR by Country
      • 7.1.1 Europe Pet DR Sales by Country (2018-2023)
      • 7.1.2 Europe Pet DR Revenue by Country (2018-2023)
    • 7.2 Europe Pet DR Sales by Type
    • 7.3 Europe Pet DR Sales by Application
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Pet DR by Country
      • 8.1.1 Middle East & Africa Pet DR Sales by Country (2018-2023)
      • 8.1.2 Middle East & Africa Pet DR Revenue by Country (2018-2023)
    • 8.2 Middle East & Africa Pet DR Sales by Type
    • 8.3 Middle East & Africa Pet DR Sales by Application
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Pet DR
    • 10.3 Manufacturing Process Analysis of Pet DR
    • 10.4 Industry Chain Structure of Pet DR
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Pet DR Distributors
    • 11.3 Pet DR Customer
  • 12 World Forecast Review for Pet DR by Geographic Region

    • 12.1 Global Pet DR Market Size Forecast by Region
      • 12.1.1 Global Pet DR Forecast by Region (2024-2029)
      • 12.1.2 Global Pet DR Annual Revenue Forecast by Region (2024-2029)
    • 12.2 Americas Forecast by Country
    • 12.3 APAC Forecast by Region
    • 12.4 Europe Forecast by Country
    • 12.5 Middle East & Africa Forecast by Country
    • 12.6 Global Pet DR Forecast by Type
    • 12.7 Global Pet DR Forecast by Application
  • 13 Key Players Analysis

    • 13.1 Visaris
      • 13.1.1 Visaris Company Information
      • 13.1.2 Visaris Pet DR Product Portfolios and Specifications
      • 13.1.3 Visaris Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.1.4 Visaris Main Business Overview
      • 13.1.5 Visaris Latest Developments
    • 13.2 Carestream
      • 13.2.1 Carestream Company Information
      • 13.2.2 Carestream Pet DR Product Portfolios and Specifications
      • 13.2.3 Carestream Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.2.4 Carestream Main Business Overview
      • 13.2.5 Carestream Latest Developments
    • 13.3 Americomp
      • 13.3.1 Americomp Company Information
      • 13.3.2 Americomp Pet DR Product Portfolios and Specifications
      • 13.3.3 Americomp Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.3.4 Americomp Main Business Overview
      • 13.3.5 Americomp Latest Developments
    • 13.4 Mednva
      • 13.4.1 Mednva Company Information
      • 13.4.2 Mednva Pet DR Product Portfolios and Specifications
      • 13.4.3 Mednva Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.4.4 Mednva Main Business Overview
      • 13.4.5 Mednva Latest Developments
    • 13.5 Basda
      • 13.5.1 Basda Company Information
      • 13.5.2 Basda Pet DR Product Portfolios and Specifications
      • 13.5.3 Basda Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.5.4 Basda Main Business Overview
      • 13.5.5 Basda Latest Developments
    • 13.6 BMI Biomedical International
      • 13.6.1 BMI Biomedical International Company Information
      • 13.6.2 BMI Biomedical International Pet DR Product Portfolios and Specifications
      • 13.6.3 BMI Biomedical International Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.6.4 BMI Biomedical International Main Business Overview
      • 13.6.5 BMI Biomedical International Latest Developments
    • 13.7 Agfa-Gevaert Group
      • 13.7.1 Agfa-Gevaert Group Company Information
      • 13.7.2 Agfa-Gevaert Group Pet DR Product Portfolios and Specifications
      • 13.7.3 Agfa-Gevaert Group Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.7.4 Agfa-Gevaert Group Main Business Overview
      • 13.7.5 Agfa-Gevaert Group Latest Developments
    • 13.8 Onex Corporation
      • 13.8.1 Onex Corporation Company Information
      • 13.8.2 Onex Corporation Pet DR Product Portfolios and Specifications
      • 13.8.3 Onex Corporation Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.8.4 Onex Corporation Main Business Overview
      • 13.8.5 Onex Corporation Latest Developments
    • 13.9 CONTROL-X Medical
      • 13.9.1 CONTROL-X Medical Company Information
      • 13.9.2 CONTROL-X Medical Pet DR Product Portfolios and Specifications
      • 13.9.3 CONTROL-X Medical Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.9.4 CONTROL-X Medical Main Business Overview
      • 13.9.5 CONTROL-X Medical Latest Developments
    • 13.10 Examion
      • 13.10.1 Examion Company Information
      • 13.10.2 Examion Pet DR Product Portfolios and Specifications
      • 13.10.3 Examion Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.10.4 Examion Main Business Overview
      • 13.10.5 Examion Latest Developments
    • 13.11 IBIS X Ray Systems
      • 13.11.1 IBIS X Ray Systems Company Information
      • 13.11.2 IBIS X Ray Systems Pet DR Product Portfolios and Specifications
      • 13.11.3 IBIS X Ray Systems Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.11.4 IBIS X Ray Systems Main Business Overview
      • 13.11.5 IBIS X Ray Systems Latest Developments
    • 13.12 Heska
      • 13.12.1 Heska Company Information
      • 13.12.2 Heska Pet DR Product Portfolios and Specifications
      • 13.12.3 Heska Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.12.4 Heska Main Business Overview
      • 13.12.5 Heska Latest Developments
    • 13.13 Air Techniques
      • 13.13.1 Air Techniques Company Information
      • 13.13.2 Air Techniques Pet DR Product Portfolios and Specifications
      • 13.13.3 Air Techniques Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.13.4 Air Techniques Main Business Overview
      • 13.13.5 Air Techniques Latest Developments
    • 13.14 Dawei Medical
      • 13.14.1 Dawei Medical Company Information
      • 13.14.2 Dawei Medical Pet DR Product Portfolios and Specifications
      • 13.14.3 Dawei Medical Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.14.4 Dawei Medical Main Business Overview
      • 13.14.5 Dawei Medical Latest Developments
    • 13.15 Shenzhen Mindray Animal Medical Technology
      • 13.15.1 Shenzhen Mindray Animal Medical Technology Company Information
      • 13.15.2 Shenzhen Mindray Animal Medical Technology Pet DR Product Portfolios and Specifications
      • 13.15.3 Shenzhen Mindray Animal Medical Technology Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.15.4 Shenzhen Mindray Animal Medical Technology Main Business Overview
      • 13.15.5 Shenzhen Mindray Animal Medical Technology Latest Developments
    • 13.16 Suzhou Genray Technology
      • 13.16.1 Suzhou Genray Technology Company Information
      • 13.16.2 Suzhou Genray Technology Pet DR Product Portfolios and Specifications
      • 13.16.3 Suzhou Genray Technology Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.16.4 Suzhou Genray Technology Main Business Overview
      • 13.16.5 Suzhou Genray Technology Latest Developments
    • 13.17 Shenzhen RWD
      • 13.17.1 Shenzhen RWD Company Information
      • 13.17.2 Shenzhen RWD Pet DR Product Portfolios and Specifications
      • 13.17.3 Shenzhen RWD Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.17.4 Shenzhen RWD Main Business Overview
      • 13.17.5 Shenzhen RWD Latest Developments
    • 13.18 Perlove
      • 13.18.1 Perlove Company Information
      • 13.18.2 Perlove Pet DR Product Portfolios and Specifications
      • 13.18.3 Perlove Pet DR Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.18.4 Perlove Main Business Overview
      • 13.18.5 Perlove Latest Developments
  • 14 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.